Atlas Trials

A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Clinical trial NCT04187508 · WITHDRAWN

Trial details

NCT number
NCT04187508
Sponsor
AstraZeneca
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2020-02-06
Primary completion
2021-11-10
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.